EMCDDA Home
  • EN
Search

Table TDI-104. New clients entering inpatient treatment by primary drug and age, 2011 or most recent year available

Part (iv) New hallucinogen inpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium00000000000
Bulgaria00000000000
Czech Republic00100000101
Denmark00000000000
Germany0045301013013
Estonia:::::::::::
Ireland100001100202
Greece00000000000
Spain:::::::::::
France00000000000
Italy:::::::::::
Cyprus00000000000
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary00000100101
Malta:::::::::::
Netherlands00111000303
Austria00010000101
Poland2:1:::::::::
Portugal:::::::::::
Romania04112000808
Slovenia:::::::::::
Slovakia00000000000
Finland00000000000
Sweden100100000101
United Kingdom301240000707
Croatia:51::::::::
Turkey00000000000
Norway:::::::::::
Total0111112721037037
 

Notes:

: Indicates no data are available.

(1) Data are from 2010.

(2) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data. Heroin includes both heroin and so called 'kompot' (heroin gained from the poppy straws).

(3) Data are from 1st of April 2010 to 31st March 2011.

See also Table TDI-10 part(v), part(vi)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Inpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013